A new publication titled "Orforglipron: An Oral GLP-1 Receptor Agonist for Obesity Treatment" appeared on September 18, 2026. It was published in The Annals of Pharmacotherapy. The publication is indexed under PubMed ID 42760621. No findings, results, or efficacy data from this publication have been provided beyond its title and appearance in the journal. This item is noted here as a record of publication only, not as a summary of study conclusions. Readers seeking details of the publication's content should consult the original source directly. For general context on related GLP-1 receptor agonist compounds, including liraglutide, readers can consult the compound overview page.
New Publication on Orforglipron Indexed in Annals of Pharmacotherapy
See the full liraglutide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42760621/